The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2: Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?

AIM: SARS-CoV-2 infection has been divided by scientific opinion into three phases: the first as asymptomatic or slightly symptomatic and the second and the third with greater severity, characterized by a hyperinflammatory and fibrotic state, responsible for lung lesions, in some cases fatal. The de...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrara, Francesco, Granata, Giovanni, Pelliccia, Chiara, La Porta, Raffaele, Vitiello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320911/
https://www.ncbi.nlm.nih.gov/pubmed/32594204
http://dx.doi.org/10.1007/s00228-020-02947-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320911/
https://www.ncbi.nlm.nih.gov/pubmed/32594204
http://dx.doi.org/10.1007/s00228-020-02947-4

Ejemplares similares